COMMUNIQUÉS West-GlobeNewswire

V ClinBio Acquires 49.98% Stake in Cellix to Advance Synergix, a Transformative Pro-drug Technology Platform

06/02/2018 - 17:15

- Lead compounds for the treatment of relapsing-remitting multiple sclerosis and ulcerative colitis on target to enter clinic in 2018 - PRINCETON, N.J., Feb. 06, 2018 (GLOBE NEWSWIRE) -- V ClinBio Inc., an innovative [...]

Aviragen Adjourns Special Meeting of Stockholders Until February 9, 2018

06/02/2018 - 16:25

ATLANTA, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ: AVIR ) today announced that its Special Meeting of Stockholders, scheduled for and convened on February 6, 2018, has been adjourned to [...]

AXIM Biotech Enters Into Distribution Agreement for Proprietary Cannabinoid-Based Nutraceutical Chewing Gum Product CanChew+ Throughout Thailand

06/02/2018 - 16:00

NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM) (“AXIM”), the world leader in cannabinoid research and development, announced today that it has entered into a binding distribution [...]

Xoc Pharmaceuticals Announces $30 Million Series A Financing Led by NEA

06/02/2018 - 16:00

LOS GATOS, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Xoc Pharmaceuticals, Inc., a privately-held, early-stage biopharmaceutical company focused on the development of innovative therapeutics for diseases of the central [...]

Sienna Announces Q4 2017 Results Release Date and Conference Call

06/02/2018 - 15:32

MARKHAM, Ontario, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA ) announced that it will report its 2017 fourth quarter results after market close on Thursday, [...]

Biothera Pharmaceuticals Commences Phase 2 Head and Neck Cancer Study Evaluating Combination of Imprime PGG and Merck’s KEYTRUDA® (pembrolizumab)

06/02/2018 - 15:30

EAGAN, Minn., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. announced today that patient treatment has commenced in its Phase 2 clinical study in squamous cell carcinoma of the head and neck (SCCHN). [...]

Galectin Therapeutics to Present at BIO CEO & Investor Conference

06/02/2018 - 15:15

NORCROSS, Ga., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today announced that Peter G. Traber, M.D., the Company’s [...]

Medipure Pharmaceuticals Inc. Announces Appointment of Dr. Kaiji Hu as Research Scientist - Cell and Molecular Biology

06/02/2018 - 15:00

VANCOUVER, British Columbia, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Medipure Pharmaceuticals Inc., a biopharmaceutical incubator committed to discovering and developing proprietary cannabinoid-derived prescription [...]

When It Comes to Artificial Intelligence in Healthcare, Patients Fear the Replacement of Doctors, Yet Are Open to AI Nurse Support

06/02/2018 - 15:00

RALEIGH, N.C., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Syneos Health Communications today released a report that provides pioneering perspectives into patients’ thought processes as they confront a future with artificial [...]

NewLink Genetics to Participate in Upcoming Investor Conferences

06/02/2018 - 15:00

AMES, Iowa, Feb. 06, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) announced today that the company will participate in the following investor conferences: BIO CEO & Investor Conference, [...]

Ziopharm Oncology Addresses Rumors and Stock Volatility, Affirms 2018 Guidance

06/02/2018 - 14:55

BOSTON, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP ) today responded to unfounded rumors regarding possible financing plans of the Company. Management states that it knows of no developments [...]

Aino Health AB (publ): signs contract with ArcelorMittal

06/02/2018 - 14:40

Aino Health Germany GmbH has signed a contract with the German steel and mining company ArcelorMittal regarding use of Aino's health management services at the factory in Neuwied. The deal is the first on the German [...]

Precipio Enters Japanese Liquid Biopsy Market with First Hospital Sale

06/02/2018 - 14:37

NEW HAVEN, Conn., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ) announces its entry into the Japanese market with a first order of its ICE-COLD PCR™ (ICP) kit, Precipio’s [...]

AC Immune to Participate in Two Investor Conferences and Provide Scientific Updates at AAT-AD/PD Conference

06/02/2018 - 14:31

Lausanne, Switzerland, - February 6, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that it will [...]

Checkpoint Therapeutics to Present at BIO CEO & Investor Conference

06/02/2018 - 14:30

NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a Fortress Biotech (NASDAQ: FBIO ) company, today announced that James F. Oliviero, President and Chief Executive [...]

Mustang Bio to Participate in Immuno-Oncology Panel at BIO CEO & Investor Conference

06/02/2018 - 14:30

NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]

Agritek Holdings, Inc. Announces First Revenues From Hemp CBD Sales and New Product Lines On Heels Of National Feature Interview As Public Cannabis Company On Fox Business Network

06/02/2018 - 14:30

LOS ANGELES, CA, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis [...]

SELLAS Life Sciences to Present at Two Upcoming February Investor Conferences

06/02/2018 - 14:30

- BIO CEO & Investor Conference on February 13 - - RBC Capital Markets Healthcare Conference on February 21 - NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS), a [...]

BriaCell Opens Fourth Clinical Site in Advanced Breast Cancer

06/02/2018 - 14:30

BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 06, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]